- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06989619
- Original Trial
Leveraging Social Networks to Improve Sleep and Mindfulness Among Older Adults in Residential Housing Facilities
May 16, 2025 updated by: Rebecca Robbins, Brigham and Women's Hospital
The aim of this study is to design a sleep and mindfulness intervention to improve sleep, quality of life, and cognitive function among older adults.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The proposed R34 planning grant will the design and adapt a sleep, mindfulness, and sleep disorders education intervention entitled to cognitively unimpaired older adults residing in housing facilities.
Novel, social network techniques will be used to identify opinion leaders who will assist with message dissemination.
This grant will adapt content from an existing, evidence-based Sleep Health Program to the needs of older adults.
In addition, the adapted Sleep Health Program will be coupled with Mindfulness content then disseminated in a small pilot study to ascertain feasibility and acceptability of the proposed novel social network approach for deploying the adapted Sleep Health and Mindfulness Program in a planned R01.
The data collected in this R34 will include qualitative interview and usability interview data where cognitively unimpaired older adults will be recruited and asked to provide input to the messages and approach.
Target outcomes will also be collected in the planned pilot, including survey responses to sleep, sleep disorders evaluation/care, quality of life, and cognition.
Finally, FitBit data will also be captured for 2 weeks at several time points during the pilot study (baseline, 2-months, and 6-months).
Study Type
Interventional
Enrollment (Estimated)
45
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Chidera Ejikeme
- Phone Number: 2039792338
- Email: cejikeme@bwh.harvard.edu
Study Contact Backup
- Name: Rebecca Robbins, PhD
- Phone Number: 2039792338
- Email: rrobbins4@bwh.harvard.edu
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Recruiting
- Brigham and Women's Hospital
-
Contact:
- Rebecca Robbins, PhD
- Phone Number: 2039792338
- Email: rrobbins4@bwh.harvard.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Older adults (age 55 years of age and above) residing in residential facilities.
Exclusion Criteria:
- Severe cognitive impairment according to the Montreal Cognitive Assessment (MoCA).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Sleep Health and Mindfulness Program for Older Adults
This grant will develop and design an adapted version of an existing, effective Sleep Health Program, which will be coupled with mindfulness content, to meet the needs and unique barriers older adults in housing facilities face.
The modules for the proposed Sleep Health and Mindfulness program will be designed in collaboration with the implementation partner, the City of Boston Age Strong Commission, whose talented leaders and staff have decades of experience designing programs for seniors on a variety of topics, including mindfulness.
|
This educational, healthy lifestyle intervention will include several modules detailing sleep health and mindfulness strategies.
In addition, opinion leaders will be identified in the population to help diffuse messages through each housing facility.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time it takes to recruit
Time Frame: Baseline, 2-months, and 6-months
|
Time it takes to recruit participants into the study
|
Baseline, 2-months, and 6-months
|
|
Sessions attended
Time Frame: Baseline, 2-months, and 6-months
|
Average number of sessions the participants attend.
|
Baseline, 2-months, and 6-months
|
|
Proportion of participants who complete the program
Time Frame: Baseline, 2-months, and 6-months
|
Proportion of older adults who complete the program.
|
Baseline, 2-months, and 6-months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The score of the Pittsburgh Sleep Quality Index (PSQI)
Time Frame: Baseline, 2-months, and 6-months
|
The Pittsburgh Sleep Quality Index (PSQI) contains 19 self-rated questions which measures seven aspects of sleep: (1) subjective sleep quality, (2) sleep latency, (3) sleep duration, (4) habitual sleep efficiency, (5) sleep disturbances, (6) use of sleeping medication, and (7) daytime dysfunction.
The 19 self-rated items are combined to form seven component scores, each of which has a range of 0-3 points (0 indicates no difficulty, while 3 indicates severe difficulty).
The seven component scores are then summed to yield one global score, with a range of 0-21 points (0 indicating no difficulty, and 21 indicating severe difficulties in all the seven areas of sleep quality).
|
Baseline, 2-months, and 6-months
|
|
The Score of the Dementia Quality of Life (DEMQOL)
Time Frame: Baseline, 2-months, and 6-months
|
The Dementia Quality of Life (DEMQOL) instrument is a 28-item self-reported measure related to health-related quality-of-life (HRQL) in patients with dementia.
The DEMQOL takes cognition, negative emotion, positive emotion, social relationships, and loneliness into consideration.
|
Baseline, 2-months, and 6-months
|
|
The Score of the Montreal Cognitive Assessment (MoCA)
Time Frame: Baseline, 2-months, and 6-months
|
The MoCA (Montreal Cognitive Assessment) test is scored out of 30 points, and a score of 26 or above is generally considered normal.
A score of 26 or below may indicate some degree of cognitive impairment.
The specific cutoff score for determining impairment is 26.
|
Baseline, 2-months, and 6-months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Chair: Rebecca Robbins, PhD, PhD
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2025
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
September 15, 2026
Study Registration Dates
First Submitted
May 4, 2025
First Submitted That Met QC Criteria
May 16, 2025
First Posted (Actual)
May 25, 2025
Study Record Updates
Last Update Posted (Actual)
May 25, 2025
Last Update Submitted That Met QC Criteria
May 16, 2025
Last Verified
May 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BrighamHopsital
- R34AG089176 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
All data collected in this R34 will be fully anonymous.
Data and metadata will be made available through the NIH-funded National Sleep Research Resource (NSRR; www.SleepData.org).
Data and metadata will be assigned a unique Digital Object Identifier (DOI) and a formal study citation by the repository (NSRR).
All de-identified data will be shared by end of project period or time of publication, whichever is sooner, and will remain available indefinitely.
We estimate data will be shared no later than year 2 of this R34 planning grant.
IPD Sharing Time Frame
All de-identified data will be shared by end of project period or time of publication, whichever is sooner, and will remain available indefinitely.
We estimate data will be shared no later than year 2 of this R34 planning grant.
IPD Sharing Access Criteria
Consistent with the Brigham and Women's Hospital data sharing guidelines
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cognitive Impairment
-
Stanford UniversityRecruitingMild Cognitive Impairment | Subjective Cognitive ImpairmentUnited States
-
University of EdinburghNHS LothianNot yet recruitingCognitive Impairment | Anesthesia | Cognitive Impairment, Mild | Anesthesia Brain Monitoring | Cognitive Impairment, Progressive | Anesthesia Depth MonitoringUnited Kingdom
-
Fondazione Don Carlo Gnocchi OnlusUniversity of Florence; Consorzio di Bioingeneria e Informatica Medica; Gutenberg...CompletedCognitive Dysfunction | Mild Cognitive Impairment | Vascular Cognitive ImpairmentItaly
-
University of California, Los AngelesCompletedMild Cognitive Impairment (MCI) | Age-associated Cognitive ImpairmentUnited States
-
Universidad de ZaragozaRecruitingMild Cognitive Impairment | Randomized Controlled Trial | Subjective Cognitive ImpairmentSpain
-
BaycrestCentre for Aging and Brain Health InnovationUnknownNeurocognitive Disorders | Cognitive Dysfunction | Mental Disorder | Cognitive Impairment, Mild | Cognitive Disorder | Nonamnestic Mild Cognitive ImpairmentCanada
-
Region SkaneLund University; Berry LabCompletedMemory Impairment | Cognitive Impairment, MildSweden
-
Sunnybrook Health Sciences CentreRecruitingMild Cognitive Impairment | Vascular Cognitive ImpairmentCanada
-
University of GeorgiaApplied Universal Dynamics, Corp.; Van Robotics, Inc.Active, not recruitingRobot-assisted Cognitive Training for Lonely Older Adults With Mild Cognitive Impairment (MCI) (MCI)Cognitive Change | Aging | Cognitive Impairment, MildUnited States
-
University of HawaiiRecruitingMild Cognitive Impairment | Subjective Cognitive ImpairmentUnited States
Clinical Trials on Sleep health and mindfulness intervention
-
Solveig MagnusdottirAkureyri HospitalCompletedDepression | Sleep | Anxiety | ChronotypeIceland
-
Medical College of WisconsinTerminatedMultiple Myeloma | SleepUnited States
-
Central South UniversityUnknown
-
Chung Shan Medical UniversityChanghua Christian HospitalUnknownWeight Loss | Health Promotion | Mindfulness | WorkplaceTaiwan
-
Northwestern UniversityUniversity of Virginia; Tiny Blue Dot FoundationCompletedAnxietyUnited States
-
University of Kansas Medical CenterCompleted
-
University of Colorado, BoulderCompletedSleep | Emotions
-
University of PittsburghNational Institute of Mental Health (NIMH)Active, not recruiting
-
The Hong Kong Polytechnic UniversityRecruitingCOVID-19 InfectionHong Kong
-
Columbia UniversityRecruitingSleep | Blood Pressure | Cardiovascular HealthUnited States